CMF (chemotherapy): Difference between revisions

@@ Line 4: / Line 4: @@
 '''Cyclophosphamide Methotrexate Fluorouracil (CMF)''' is a commonly used [[Chemotherapy regimens|regimen]] of [[breast cancer chemotherapy]].
-It is named for the three medicines that comprise the therapy: [[cyclophosphamide]], [[methotrexate]], and [[Fluorouracil|5-fluorouracil]].
+It is named for the three medicines that comprise the therapy: [[cyclophosphamide]], [[methotrexate]], and [[Fluorouracil|5-fluorouracil]].<ref name="pmid18306034">{{cite journal |author=Kimmick GG, Cirrincione C, Duggan DB, ''et al'' |title=Fifteen-year median follow-up results after neoadjuvant doxorubicin, followed by mastectomy, followed by adjuvant cyclophosphamide, methotrexate, and fluorouracil (CMF) followed by radiation for stage III breast cancer: a phase II trial (CALGB 8944) |journal=[[Breast Cancer Res. Treat.]] |volume= |issue= |pages= |year=2008 |pmid=18306034 |doi=10.1007/s10549-008-9943-2 |url=http://dx.doi.org/10.1007/s10549-008-9943-2}}</ref>
+==References==
+{{reflist}}
 [[Category:Chemotherapeutic agents]]